对帕金森病的综合方法:解决其分子,临床和治疗方面的问题
Mauricio Muleiro Alvarez1, Gabriela Cano-Herrera1, María Fernanda Osorio Martínez1
1Centro de Investigación en Ciencias de la Salud (CICSA), Facultad de Ciencias de la Salud, Universidad Anáhuac Campus México Norte, Huixquilucan 52786, Mexico.
International journal of molecular sciences
|July 13, 2024
概括
帕金森病 (PD) 是一种进展性神经退行性疾病,影响全球数百万人. 本综述比较了传统和新型治疗方法,包括药物,生活方式改变和手术选择,以管理PD症状和进展.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 帕金森病 (PD) 是第二个最常见的神经退行性疾病,影响全球超过600万人.
- 它的病因是多因素的,涉及环境,基因组和表观遗传因素.
- 临床表现包括非运动和运动症状,运动缺陷是特征.
研究的目的:
- 为了提供对帕金森病的全面审查.
- 为了比较传统和PD的最新治疗进展.
- 探索用于神经保护和减轻PD症状的新兴治疗方法.
主要方法:
- 对药理干预措施的审查 (MAOI,DA,乐伏多巴,抗糖尿病药物,基因疗法).
- 分析非药理学方法 (运动,饮食,维生素D).
- 评估手术选择 (深度大脑刺激,肠道凝输液).
主要成果:
- 传统的治疗方法包括诸如利沃多巴等药物.
- 新兴疗法显示了神经保护和症状管理的潜力.
- 像深度大脑刺激这样的外科干预改善了运动症状,而肠道凝输液减少了"关闭"时间.
结论:
- 目前PD的治疗策略包括药物,非药物和手术干预.
- 新型治疗方法,包括抗糖尿病药物和基因疗法,提供有前途的神经保护作用.
- 进一步的研究对于优化现有治疗方法和开发新的帕金森病管理替代方案至关重要.
相关概念视频
01:15Parkinson's Disease: Overview
522
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
522
01:24Parkinson's Disease: Treatment
251
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
251
01:26Alzheimer's Disease: Overview
461
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
461
01:37Neural Regulation
39.3K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.3K
01:28Drug Therapy
41
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
41
01:28Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K